Macrophagic myofasciitis: A report of second case from UK

Neuropathology and Applied Neurobiology

Volumn 38, Issue 7, 2012, Pages 734-736

  Shivane, A ^a   Hilton, D A ^a   Moate, R M ^b   Bond, P R ^b   Endean, A ^c  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

^c ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADULT; ARTHRALGIA; CASE REPORT; CLINICAL FEATURE; FASCIITIS; FEMALE; HUMAN; LETTER; MACROPHAGIC MYOFASCIITIS; MEMORY DISORDER; METACARPOPHALANGEAL JOINT; MORNING STIFFNESS; NEUROPATHIC PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

FASCIITIS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS;

EID: 84869130551     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2012.01293.x     Document Type: Letter

References (12)

1. Gherardi RK, Coquet M, Che'rin P, Authier FJ, Laforet P, Belec L, Figarella-Branger D, Mussini JM, Pellissier JF, Fardeau M. Macrophagic myofasciitis: an emerging entity. Lancet 1998; 352: 347-52
2. Gherardi RK, Coquet M, Che'rin P, Belec L, Moretto P, Dreyfus PA, Pellisier JF, Chariot P, Authier FJ. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001; 124: 1821-31
3. Gherardi RK, Authier FJ. Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am 2003; 23: 699-712
4. Shoenfeld Y, Agmon-Levin N. 'ASIA'- autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4-8
5. Crooks D, Bajalan AAA. Macrophagic myofasciitis in Britain. Neuropathol Appl Neurobiol 2001; 27: 158
6. Gherardi RK, Authier FJ. Macrophagic myofasciitis: characterisation and pathophysiology. Lupus 2012; 21: 184-9
7. Nevo Y, Kutai M, Jossiphov J, Livne A, Neeman Z, Arad T, Popovitz-Biro R, Atsmon J, Shapira Y, Soffer D. Childhood macrophagic myofasciitis-consanguinity and clinicopathological features. Neuromuscul Disord 2004; 14: 246-52
8. Ryan AM, Bermingham N, Harrington HJ, Keohane C. Atypical presentation of macrophagic myofasciitis 10 years post vaccination. Neuromuscul Disord 2006; 16: 867-9
9. Che'rin P, Authier FJ, Gherardi RK, Romero N, Laforet P, Eymard B, Herson S, Caillat-Vigneron N. Gallium-67 scintigraphy in macrophagic myofasciitis. Arthritis Rheum 2000; 43: 1520-6
10. Guis S, Pellissier JF, Nicoli F, Reviron D, Mattei JP, Gherardi RK, Pelletier J, Kaplanski G, Figarella-Branger D, Roudier J. HLA-DRB1*01 and macrophagic myofasciitis. Arthritis Rheum 2002; 46: 2535-7
11. Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A, Ranoux D, Pelletier J, Figarella-Branger D, Granel B, Maisonobe T, Coquet M, Degos JD, Gherardi RK. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001; 124: 974-83
12. Passeri E, Villa C, Couette M, Itti E, Brugieres P, Cesaro P, Gherardi RK, Bachoud-Levi AC, Authier FJ. Long-term follow-up of cognitive dysfunction in patients with aluminium hydroxide-induced macrophagic myofasciitis. J Inorg Biochem 2011; 105: 1457-63